Faraz Khan, MD
Vascular & Interventional Radiology · Reston, VANPI 1770087850
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Terumo Medical Corporation at 54.3% of the total.
Across 31 payments — averaging $150.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$3K
- Penumbra, Inc.$2K
- Boston Scientific$211
- Inari Medical, Inc.$180
- Bioprotect Medical, Inc.$65
- Angiodynamics, Inc.$58
- plus $52 from 2 others
What the payments were for
- Consulting fees$2,20047%
- Travel & lodging$1,34729%
- Food & beverage$1,12824%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 8 | $2,540 |
| Penumbra, Inc. | 5 | $1,569 |
| Boston Scientific | 9 | $211 |
| Inari Medical, Inc. | 2 | $180 |
| Bioprotect Medical, Inc. | 2 | $65 |
| Angiodynamics, Inc. | 3 | $58 |
| Siemens Medical Solutions USA, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROGREAT$2,200
- Indigo System$1,534
- ANGIO-SEAL$156
- FLOWTRIEVER CATHETER, S$156
- CT THROMBECTOMY SYSTEM KIT$156
How this compares
$4,675 in reported general payments places this provider in the 60th percentile of 136 vascular & interventional radiology providers in Virginia.
See all vascular & interventional radiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 15 | $208 |
| Methylprednisolone | 20 | $143 |
| Cefadroxil | 17 | $39 |
| Ibuprofen | 19 | $34 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $27 |
| Famotidine | 20 | $16 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Reston
- Alex PavidaphaReston$13K
- Rachel PiechowiakReston$5K
- Jeffrey HullRichmond$10.8M
- Ziv HaskalCharlottesville$724K
- Keith SterlingSpringfield$357K
- John GaughenCharlottesville$253K
- Jawad HussainRichmond$248K
- Sandeep BaglaFalls Church$146K
- Aaron DucoffeFairfax$108K
- Ryan McTaggartRoanoke$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.